Article Details
Retrieved on: 2023-10-03 06:20:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... POSLUMA® (flotufolastat F 18) PET in suspected biochemical recurrence of prostate cancer. The analysis examined the detection rate (% positiv.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here